Search Results - "Borbulevych, Oleg Y"

Refine Results
  1. 1

    Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics by Borbulevych, Oleg Y, Piepenbrink, Kurt H, Baker, Brian M

    Published in The Journal of immunology (1950) (01-03-2011)
    “…Molecular mimicry between foreign and self Ags is a mechanism of TCR cross-reactivity and is thought to contribute to the development of autoimmunity. The αβ…”
    Get full text
    Journal Article
  2. 2

    Disparate Degrees of Hypervariable Loop Flexibility Control T-Cell Receptor Cross-Reactivity, Specificity, and Binding Mechanism by Scott, Daniel R., Borbulevych, Oleg Y., Piepenbrink, Kurt H., Corcelli, Steven A., Baker, Brian M.

    Published in Journal of molecular biology (02-12-2011)
    “…αβ T-cell receptors (TCRs) recognize multiple antigenic peptides bound and presented by major histocompatibility complex molecules. TCR cross-reactivity has…”
    Get full text
    Journal Article
  3. 3

    Fluorine substitutions in an antigenic peptide selectively modulate T-cell receptor binding in a minimally perturbing manner by Piepenbrink, Kurt H, Borbulevych, Oleg Y, Sommese, Ruth F, Clemens, John, Armstrong, Kathryn M, Desmond, Clare, Do, Priscilla, Baker, Brian M

    Published in Biochemical journal (01-11-2009)
    “…TCR (T-cell receptor) recognition of antigenic peptides bound and presented by MHC (major histocompatibility complex) molecules forms the basis of the cellular…”
    Get more information
    Journal Article
  4. 4

    TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms by Borbulevych, Oleg Y, Santhanagopolan, Sujatha M, Hossain, Moushumi, Baker, Brian M

    Published in The Journal of immunology (1950) (01-09-2011)
    “…T cells engineered to express TCRs specific for tumor Ags can drive cancer regression. The first TCRs used in cancer gene therapy, DMF4 and DMF5, recognize two…”
    Get full text
    Journal Article
  5. 5

    The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design by Borbulevych, Oleg Y., Martin, Roger I., Westerhoff, Lance M.

    Published in Journal of computer-aided molecular design (01-04-2021)
    “…Conventional protein:ligand crystallographic refinement uses stereochemistry restraints coupled with a rudimentary energy functional to ensure the correct…”
    Get full text
    Journal Article
  6. 6

    MovableType Software for Fast Free Energy-Based Virtual Screening: Protocol Development, Deployment, Validation, and Assessment by Zheng, Zheng, Borbulevych, Oleg Y, Liu, Hao, Deng, Jianpeng, Martin, Roger I, Westerhoff, Lance M

    “…For decades, the complicated energy surfaces found in macromolecular protein:ligand structures, which require large amounts of computational time and resources…”
    Get full text
    Journal Article
  7. 7

    T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility by Borbulevych, Oleg Y., Piepenbrink, Kurt H., Gloor, Brian E., Scott, Daniel R., Sommese, Ruth F., Cole, David K., Sewell, Andrew K., Baker, Brian M.

    Published in Immunity (Cambridge, Mass.) (18-12-2009)
    “…T cell-mediated immunity requires T cell receptor (TCR) cross-reactivity, the mechanisms behind which remain incompletely elucidated. The αβ TCR A6 recognizes…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design by Insaidoo, Francis K, Borbulevych, Oleg Y, Hossain, Moushumi, Santhanagopolan, Sujatha M, Baxter, Tiffany K, Baker, Brian M

    Published in The Journal of biological chemistry (18-11-2011)
    “…Modification of the primary anchor positions of antigenic peptides to improve binding to major histocompatibility complex (MHC) proteins is a commonly used…”
    Get full text
    Journal Article
  10. 10

    Probing Dimerization and Structural Flexibility of Mammalian Lipoxygenases by Small-Angle X-ray Scattering by Shang, Weifeng, Ivanov, Igor, Svergun, Dmitri I., Borbulevych, Oleg Y., Aleem, Ansari M., Stehling, Sabine, Jankun, Jerzy, Kühn, Hartmut, Skrzypczak-Jankun, Ewa

    Published in Journal of molecular biology (17-06-2011)
    “…Human lipoxygenases (LOXs) and their metabolites have a great impact on human homeostasis and are of interest for targeted drug design. This goal requires…”
    Get full text
    Journal Article
  11. 11

    Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: Implications for WT1-based cancer therapeutics by Borbulevych, Oleg Y., Do, Priscilla, Baker, Brian M.

    Published in Molecular immunology (01-09-2010)
    “…Presentation of peptides by class I or class II major histocompatibility complex (MHC) molecules is required for the initiation and propagation of a T…”
    Get full text
    Journal Article
  12. 12

    Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition by Borbulevych, Oleg Y, Insaidoo, Francis K, Baxter, Tiffany K, Powell, Jr, Daniel J, Johnson, Laura A, Restifo, Nicholas P, Baker, Brian M

    Published in Journal of molecular biology (05-10-2007)
    “…Small structural changes in peptides presented by major histocompatibility complex (MHC) molecules often result in large changes in immunogenicity, supporting…”
    Get full text
    Journal Article
  13. 13

    Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 Å resolution by Borbulevych, Oleg Y., Jankun, Jerzy, Selman, Steven H., Skrzypczak-Jankun, Ewa

    “…PUFA metabolites have a profound effect on inflammatory diseases and cancer progression. Blocking their production by inhibiting PUFA metabolizing enzymes…”
    Get full text
    Journal Article
  14. 14

    Increased Immunogenicity of an Anchor-Modified Tumor-Associated Antigen Is Due to the Enhanced Stability of the Peptide/MHC Complex: Implications for Vaccine Design by Borbulevych, Oleg Y, Baxter, Tiffany K, Yu, Zhiya, Restifo, Nicholas P, Baker, Brian M

    Published in The Journal of immunology (1950) (15-04-2005)
    “…The use of "anchor-fixed" altered peptide ligands is of considerable interest in the development of therapeutic vaccines for cancer and infectious diseases,…”
    Get full text
    Journal Article
  15. 15

    Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode by Cole, David K, Sami, Malkit, Scott, Daniel R, Rizkallah, Pierre J, Borbulevych, Oleg Y, Todorov, Penio T, Moysey, Ruth K, Jakobsen, Bent K, Boulter, Jonathan M, Baker, Brian M, Yi Li

    Published in Frontiers in immunology (01-01-2013)
    “…Natural T cell receptors (TCRs) generally bind to their cognate pMHC molecules with weak affinity and fast kinetics, limiting their use as therapeutic agents…”
    Get full text
    Journal Article
  16. 16

    T Cell Receptor Recognition via Cooperative Conformational Plasticity by Gagnon, Susan J., Borbulevych, Oleg Y., Davis-Harrison, Rebecca L., Turner, Richard V., Damirjian, Marale, Wojnarowicz, Alison, Biddison, William E., Baker, Brian M.

    Published in Journal of molecular biology (13-10-2006)
    “…Although T cell receptor cross-reactivity is a fundamental property of the immune system and is implicated in numerous autoimmune pathologies, the molecular…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Soybean lipoxygenase-3 in complex with 4-­nitrocatechol by Skrzypczak-Jankun, Ewa, Borbulevych, Oleg Y., Jankun, Jerzy

    “…4‐Nitrocatechol (4NC) is a known inhibitor of lipoxygenase. This work presents the X‐ray structure of soybean lipoxygenase‐3 in complex with 4NC refined at…”
    Get full text
    Journal Article
  19. 19
  20. 20